Multiple comparisons and multiple contrasts in randomized dose-response trials: Confidence interval oriented approaches

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Ludwig A. Hothorn

Research Organisations

View graph of relations

Details

Original languageEnglish
Pages (from-to)711-731
Number of pages21
JournalJournal of Biopharmaceutical Statistics
Volume16
Issue number5
Publication statusPublished - 1 Oct 2006

Abstract

According to the ICH E9 recommendation, the evaluation of randomized dose-finding trials focuses on the graphical presentation of different kinds of simultaneous confidence intervals: i) superiority of at least one dose vs. placebo with and without the assumption of order restriction, ii) noninferiority of at least one dose vs. active control, iii) identification of the minimum effective dose, iv) identification of the peak dose, v) identification of the maximum safe dose for a safety endpoint, and vi) estimation of simultaneous confidence intervals for "many-to-one-by-condition interaction contrasts." Moreover, global tests for a monotone trend or a trend with a possible downturn effect are discussed. The basic approach involved obtaining multiple contrasts for different problem-related contrast definitions. For all approaches, definitions of relevance margins for superiority or noninferiority are needed. Because consensus on margins only exists for selected therapeutic areas and the definition of absolute thresholds may be difficult, simultaneous confidence intervals for ratio to placebo were also used. All approaches are demonstrated in an example-based manner using the R-packages multcomp (difference), for hypotheses based on difference, and mratios (ratio), for hypotheses based on ratios.

Keywords

    Multiple contrasts, Randomized dose-finding trials, Simultaneous confidence intervals, Trend test

ASJC Scopus subject areas

Cite this

Multiple comparisons and multiple contrasts in randomized dose-response trials: Confidence interval oriented approaches. / Hothorn, Ludwig A.
In: Journal of Biopharmaceutical Statistics, Vol. 16, No. 5, 01.10.2006, p. 711-731.

Research output: Contribution to journalArticleResearchpeer review

Download
@article{c38d3f9c0d374b7e87c14c27b2a449be,
title = "Multiple comparisons and multiple contrasts in randomized dose-response trials: Confidence interval oriented approaches",
abstract = "According to the ICH E9 recommendation, the evaluation of randomized dose-finding trials focuses on the graphical presentation of different kinds of simultaneous confidence intervals: i) superiority of at least one dose vs. placebo with and without the assumption of order restriction, ii) noninferiority of at least one dose vs. active control, iii) identification of the minimum effective dose, iv) identification of the peak dose, v) identification of the maximum safe dose for a safety endpoint, and vi) estimation of simultaneous confidence intervals for {"}many-to-one-by-condition interaction contrasts.{"} Moreover, global tests for a monotone trend or a trend with a possible downturn effect are discussed. The basic approach involved obtaining multiple contrasts for different problem-related contrast definitions. For all approaches, definitions of relevance margins for superiority or noninferiority are needed. Because consensus on margins only exists for selected therapeutic areas and the definition of absolute thresholds may be difficult, simultaneous confidence intervals for ratio to placebo were also used. All approaches are demonstrated in an example-based manner using the R-packages multcomp (difference), for hypotheses based on difference, and mratios (ratio), for hypotheses based on ratios.",
keywords = "Multiple contrasts, Randomized dose-finding trials, Simultaneous confidence intervals, Trend test",
author = "Hothorn, {Ludwig A.}",
year = "2006",
month = oct,
day = "1",
doi = "10.1080/10543400600860576",
language = "English",
volume = "16",
pages = "711--731",
journal = "Journal of Biopharmaceutical Statistics",
issn = "1054-3406",
publisher = "Taylor and Francis Ltd.",
number = "5",

}

Download

TY - JOUR

T1 - Multiple comparisons and multiple contrasts in randomized dose-response trials

T2 - Confidence interval oriented approaches

AU - Hothorn, Ludwig A.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - According to the ICH E9 recommendation, the evaluation of randomized dose-finding trials focuses on the graphical presentation of different kinds of simultaneous confidence intervals: i) superiority of at least one dose vs. placebo with and without the assumption of order restriction, ii) noninferiority of at least one dose vs. active control, iii) identification of the minimum effective dose, iv) identification of the peak dose, v) identification of the maximum safe dose for a safety endpoint, and vi) estimation of simultaneous confidence intervals for "many-to-one-by-condition interaction contrasts." Moreover, global tests for a monotone trend or a trend with a possible downturn effect are discussed. The basic approach involved obtaining multiple contrasts for different problem-related contrast definitions. For all approaches, definitions of relevance margins for superiority or noninferiority are needed. Because consensus on margins only exists for selected therapeutic areas and the definition of absolute thresholds may be difficult, simultaneous confidence intervals for ratio to placebo were also used. All approaches are demonstrated in an example-based manner using the R-packages multcomp (difference), for hypotheses based on difference, and mratios (ratio), for hypotheses based on ratios.

AB - According to the ICH E9 recommendation, the evaluation of randomized dose-finding trials focuses on the graphical presentation of different kinds of simultaneous confidence intervals: i) superiority of at least one dose vs. placebo with and without the assumption of order restriction, ii) noninferiority of at least one dose vs. active control, iii) identification of the minimum effective dose, iv) identification of the peak dose, v) identification of the maximum safe dose for a safety endpoint, and vi) estimation of simultaneous confidence intervals for "many-to-one-by-condition interaction contrasts." Moreover, global tests for a monotone trend or a trend with a possible downturn effect are discussed. The basic approach involved obtaining multiple contrasts for different problem-related contrast definitions. For all approaches, definitions of relevance margins for superiority or noninferiority are needed. Because consensus on margins only exists for selected therapeutic areas and the definition of absolute thresholds may be difficult, simultaneous confidence intervals for ratio to placebo were also used. All approaches are demonstrated in an example-based manner using the R-packages multcomp (difference), for hypotheses based on difference, and mratios (ratio), for hypotheses based on ratios.

KW - Multiple contrasts

KW - Randomized dose-finding trials

KW - Simultaneous confidence intervals

KW - Trend test

UR - http://www.scopus.com/inward/record.url?scp=33751578255&partnerID=8YFLogxK

U2 - 10.1080/10543400600860576

DO - 10.1080/10543400600860576

M3 - Article

C2 - 17037267

AN - SCOPUS:33751578255

VL - 16

SP - 711

EP - 731

JO - Journal of Biopharmaceutical Statistics

JF - Journal of Biopharmaceutical Statistics

SN - 1054-3406

IS - 5

ER -